Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.

Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, Kawashima M, Aiba Y, Nakamura H, Kouno H, Kouno H, Ohta H, Sugi K, Nikami T, Yamashita T, Katsushima S, Komeda T, Ario K, Naganuma A, Shimada M, Hirashima N, Yoshizawa K, Makita F, Furuta K, Kikuchi M, Naeshiro N, Takahashi H, Mano Y, Yamashita H, Matsushita K, Tsunematsu S, Yabuuchi I, Nishimura H, Shimada Y, Yamauchi K, Komatsu T, Sugimoto R, Sakai H, Mita E, Koda M, Nakamura Y, Kamitsukasa H, Sato T, Nakamuta M, Masaki N, Takikawa H, Tanaka A, Ohira H, Zeniya M, Abe M, Kaneko S, Honda M, Arai K, Arinaga-Hino T, Hashimoto E, Taniai M, Umemura T, Joshita S, Nakao K, Ichikawa T, Shibata H, Takaki A, Yamagiwa S, Seike M, Sakisaka S, Takeyama Y, Harada M, Senju M, Yokosuka O, Kanda T, Ueno Y, Ebinuma H, Himoto T, Murata K, Shimoda S, Nagaoka S, Abiru S, Komori A, Migita K, Ito M, Yatsuhashi H, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M.

Sci Rep. 2019 Jan 14;9(1):102. doi: 10.1038/s41598-018-36490-1.

2.

HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4/DR8 heterozygous genotype.

Oka S, Furukawa H, Yasunami M, Kawasaki A, Nakamura H, Nakamura M, Komori A, Abiru S, Nagaoka S, Hashimoto S, Naganuma A, Naeshiro N, Yoshizawa K, Yamashita H, Ario K, Ohta H, Sakai H, Yabuuchi I, Takahashi A, Abe K, Yatsuhashi H, Tohma S, Ohira H, Tsuchiya N, Migita K.

PLoS One. 2017 Oct 31;12(10):e0187325. doi: 10.1371/journal.pone.0187325. eCollection 2017.

3.

Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection.

Morishita N, Hiramatsu N, Oze T, Urabe A, Tahata Y, Yamada R, Yakushijin T, Hosui A, Iio S, Yamada A, Hagiwara H, Mita E, Yamada Y, Ito T, Inada M, Katayama K, Yabuuchi I, Imai Y, Hikita H, Sakamori R, Yoshida Y, Tatsumi T, Hayashi N, Takehara T.

Hepatol Res. 2017 Jul;47(8):773-782. doi: 10.1111/hepr.12817. Epub 2016 Oct 26.

PMID:
27593967
4.

Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003.

Tanaka H, Imai Y, Hiramatsu N, Ito Y, Imanaka K, Oshita M, Hijioka T, Katayama K, Yabuuchi I, Yoshihara H, Inoue A, Kato M, Takehara T, Tamura S, Kasahara A, Hayashi N, Tsukuma H.

Ann Intern Med. 2008 Jun 3;148(11):820-6.

PMID:
18519928
5.

Classification of ultrasonographic images of small hepatocellular carcinoma using galactose-based contrast agent: relation between image patterns and histologic features.

Matsuda Y, Yabuuchi I, Ito T, Arima R.

J Med Ultrason (2001). 2004 Sep;31(3):111-20. doi: 10.1007/s10396-004-0018-7.

PMID:
27278746
6.

Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma.

Saeki A, Tamura S, Ito N, Kiso S, Matsuda Y, Yabuuchi I, Kawata S, Matsuzawa Y.

Cancer. 2002 Apr 1;94(7):2047-54.

7.

Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.

Tsushima H, Ito N, Tamura S, Matsuda Y, Inada M, Yabuuchi I, Imai Y, Nagashima R, Misawa H, Takeda H, Matsuzawa Y, Kawata S.

Clin Cancer Res. 2001 May;7(5):1258-62.

8.

Long-term responders without eradication of hepatitis C virus after interferon therapy: characterization of clinical profiles and incidence of hepatocellular carcinoma.

Yabuuchi I, Imai Y, Kawata S, Tamura S, Noda S, Inada M, Maeda Y, Shirai Y, Fukuzaki T, Kaji I, Ishikawa H, Matsuda Y, Nishikawa M, Seki K, Matsuzawa Y.

Liver. 2000 Jul;20(4):290-5.

PMID:
10959807
9.

Changes in serum hepatic fibrosis markers in biochemical responders to interferon therapy for chronic hepatitis C.

Fukuzaki T, Kawata S, Imai Y, Tamura S, Inada M, Maeda H, Shirai Y, Maeda Y, Yabuuchi I I, Kiriyama K, Himeno S, Toyoshima H, Nishikawa M, Kashihara T, Minami Y, Nishiuchi M, Seki K, Matsuzawa Y.

Hepatol Res. 2000 May;17(2):156-166.

PMID:
10707009
10.

Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients.

Saeki A, Tamura S, Ito N, Kiso S, Matsuda Y, Yabuuchi I, Kawata S, Matsuzawa Y.

Cancer. 2000 Mar 1;88(5):1025-9.

PMID:
10699890
11.

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group.

Imai Y, Kawata S, Tamura S, Yabuuchi I, Noda S, Inada M, Maeda Y, Shirai Y, Fukuzaki T, Kaji I, Ishikawa H, Matsuda Y, Nishikawa M, Seki K, Matsuzawa Y.

Ann Intern Med. 1998 Jul 15;129(2):94-9.

PMID:
9669992
12.

[Properties of gas (CO2) microbubbles made by hand agitation and it's contrast enhancing effect].

Matsuda Y, Yabuuchi I, Ito T.

Nihon Rinsho. 1998 Apr;56(4):866-70. Japanese.

PMID:
9577599
13.

Elevated serum lipoprotein (a) levels associated with ulcerative colitis in a young Japanese patient.

Kawabata S, Katagiri S, Negoro H, Nogami A, Yabuuchi I, Gomi M, Arima R, Tarui S.

Intern Med. 1997 Jun;36(6):389-91.

14.

Recombinant interferon-alpha-2a for treatment of chronic hepatitis C: results of a multicenter randomized controlled dose study.

Imai Y, Kawata S, Tamura S, Ito N, Seki K, Nishiuchi M, Shinji Y, Kiriyama K, Himeno S, Minami Y, Kashihara T, Kawakami F, Maeda H, Yabuuchi I, Nishioka M, Shirai Y, Fukuda K, Kiso S, Ito T, Igura T, Doi Y, Matsuzawa Y.

Liver. 1997 Apr;17(2):88-92.

PMID:
9138278
15.

Hepatocellular carcinoma in adenomatous hyperplasia: detection with contrast-enhanced US with carbon dioxide microbubbles.

Nomura Y, Matsuda Y, Yabuuchi I, Nishioka M, Tarui S.

Radiology. 1993 May;187(2):353-6.

PMID:
8386389
16.

Aromatase activity in human hepatocellular carcinoma. Relationship with the degree of histologic differentiation.

Yabuuchi I, Kawata S, Tamura S, Ito N, Matsuda Y, Nishioka M, Moriwaki K, Matsuzawa Y, Tarui S.

Cancer. 1993 Jan 1;71(1):56-61.

PMID:
8380122
17.

Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma.

Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S, Yabuuchi I, Matsuda Y, Nishioka M, Tarui S.

Cancer Res. 1991 Aug 1;51(15):4080-3.

18.

Expression of transforming growth factor-beta 1 mRNA in human hepatocellular carcinoma.

Ito N, Kawata S, Tamura S, Takaishi K, Yabuuchi I, Matsuda Y, Nishioka M, Tarui S.

Jpn J Cancer Res. 1990 Dec;81(12):1202-5.

19.

Hepatic tumors: US contrast enhancement with CO2 microbubbles.

Matsuda Y, Yabuuchi I.

Radiology. 1986 Dec;161(3):701-5.

PMID:
3024206

Supplemental Content

Loading ...
Support Center